Physician profile
Richard Hainer
NPI 1821017963
$6,782.46
in general payments reported to CMS, 2019-2025
10 companies · $2,039 in 2025
The $2,039 reported for 2025 was more than what 84% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,480 · 2020: $97.55 · 2021: $165 · 2022: $47.55 · 2023: $1,119 · 2024: $834 · 2025: $2,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,003 · Food and Beverage: $1,989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,002.76 |
| Food and Beverage | $1,989.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,772.25 | 2019-2024 | 1688, 1788, 1588 |
| Abbvie INC. | $2,039.18 | 2025 | |
| Kci USA, INC. | $919.56 | 2019 | |
| Mentor Worldwide LLC | $543.63 | 2020-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $222.81 | 2019-2022 | |
| Solventum Corporation | $147.88 | 2024 | Prevena |
| Tepha INC | $68.23 | 2019 | |
| Integra Lifesciences Corporation | $34.45 | 2020 | |
| Acumed LLC | $18.63 | 2024 | Acumed |
| Sientra, INC. | $15.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hainer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.